October’s Bioinformatics Papers of Note

Former Life Technologies CEO and Chairman Greg Lucier has joined the board of directors at Invuity, a medical device company based in San Francisco. Prior to Life Tech, Lucier was chairman and CEO of Invitorgen, which merged with Applied Biosystems in 2008 to form Life Technologies. He previously held senior management positions at General Electric including CEO and president of Medical Systems Information Technologies for GE Healthcare.

Nabsys said that Anthony Shuber has joined the company as VP and chief scientific officer. He joins the firm from Ignyta, an oncology precision medicine firm, where he served as chief technology officer. Prior to joining Ignyta, Shuber was co-founder and CTO of Predictive Biosciences, and scientific co-founder of Exact Sciences. He also previously worked for Genzyme Genetics/Integrated Genetics and Genetics Institute.

Ruby Gadelrab has been named vice president of commercial marketing for 23andMe. Gadelrab most recently served as head of marketing and commercial development at Invitae, and prior to that had worked at Affymetrix, where she most recently served as head of international marketing and clinical development. She also has worked at Life Technologies, Dharmacon, and AbGene.

Luminex President and CEO Patrick Balthrop has retired, the firm announced this week. His retirement is effective immediately, as is his retirement from the firm's board of directors. He has been succeeded as president and CEO by Nachum Shamir, who is expected to be invited to join Luminex's board of directors.

Shamir most recently served as president and CEO of Given Imaging, which was acquired by Covidien earlier this year. He previously was president of Eastman Kodak's transaction and industrial solutions business. He also was president and CEO of Scitex.

Read more:
October's Bioinformatics Papers of Note